VERMILION ENERGY (VET) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 40-F for FY2025, filed Mar 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the VET SEC filings page.
VERMILION ENERGY INC. (VET) reported $1.3B in revenue for fiscal year 2025, up 19.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of VERMILION ENERGY INC.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
VERMILION ENERGY INC.'s revenue surged 19.9% year-over-year to $1.3B, reflecting rapid business expansion. This strong growth earns a score of 18/100.
VERMILION ENERGY INC. has a moderate D/E ratio of 0.56. This balance of debt and equity financing earns a leverage score of 62/100.
Not available for VERMILION ENERGY INC., so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.
VERMILION ENERGY INC. posts a -29.4% return on equity (ROE), meaning it loses $29 for every $100 of shareholders' equity. This results in a returns score of 19/100. This is down from -1.7% the prior year.
Key Financial Metrics
Earnings & Revenue
VERMILION ENERGY INC. generated $1.3B in revenue in fiscal year 2025. This represents an increase of 19.9% from the prior year.
VERMILION ENERGY INC. reported a net loss of $476.7M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
VERMILION ENERGY INC. earned -$3.10 per diluted share (EPS) in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
Not reported for fiscal year 2025.
Cash & Balance Sheet
VERMILION ENERGY INC. held $13.9M in cash against $906.8M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
VERMILION ENERGY INC.'s net profit margin was -37.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 34.0 percentage points from the prior year.
VERMILION ENERGY INC.'s ROE was -29.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 27.8 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
VET Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2540-F | FY2440-F | FY2340-F | FY2240-F | FY2140-F | FY2040-F | FY1940-F | FY1840-F | FY1740-F | FY1640-F |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B+19.9% | $1.1B-29.4% | $1.5B-39.7% | $2.5B+58.0% | $1.6B+78.5% | $894.6M-33.6% | $1.3B+20.5% | $1.1B+36.7% | $818.4M+32.6% | $617.1M |
| Interest Expense | $96.8M+64.8% | $58.8M-9.0% | $64.5M+5.4% | $61.2M+7.1% | $57.2M-2.8% | $58.9M-6.2% | $62.8M+17.7% | $53.3M+16.5% | $45.8M+7.9% | $42.4M |
| Income Tax | $29.2M+60.0% | $18.2Mn/m | -$30.8M-105.7% | $545.4M+198.8% | $182.5Mn/m | -$282.3M-437.8% | $83.6M+37.3% | $60.9M+22.4% | $49.7Mn/m | -$47.1M |
| Net Income | -$476.7Mn/m | -$32.5Mn/m | -$180.0M-118.5% | $970.3M+7.9% | $899.0Mn/m | -$1.2B-4802.3% | $25.3M-87.3% | $199.1M+300.3% | $49.7Mn/m | -$119.2M |
| EPS (Basic) | -$3.10n/m | -$0.21n/m | -$1.10-118.5% | $5.93+6.3% | $5.58n/m | -$7.54-4751.5% | $0.16-88.5% | $1.41+240.5% | $0.42n/m | -$1.03 |
| EPS (Diluted) | -$3.10n/m | -$0.21n/m | -$1.10-119.1% | $5.76+5.7% | $5.46n/m | -$7.54-4751.5% | $0.16-88.4% | $1.40+243.6% | $0.41n/m | -$1.03 |
| Diluted Shares (Avg) | 154M-2.7% | 158M-3.5% | 164M-2.8% | 168M+2.2% | 165M+4.3% | 158M+1.2% | 156M+9.7% | 142M+16.3% | 122M+5.8% | 116M |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.
VET Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2540-F | FY2440-F | FY2340-F | FY2240-F | FY2140-F | FY2040-F | FY1940-F | FY1840-F | FY1740-F | FY1640-F |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | N/A | $4.2B-10.1% | $4.7B-8.6% | $5.2B+11.8% | $4.6B+43.4% | $3.2B-28.8% | $4.5B-1.5% | $4.6B+44.7% | $3.2B+4.3% | $3.0B |
| Current Assets | N/A | $404.4M-35.2% | $623.8M+18.1% | $528.0M+42.7% | $370.1M+80.8% | $204.7M-23.7% | $268.2M-14.9% | $315.1M+50.6% | $209.2M+24.3% | $168.3M |
| Cash & Equivalents | $13.9M-84.8% | $91.5M-14.6% | $107.1M+947.9% | $10.2M+116.7% | $4.7M-12.9% | $5.4M-75.8% | $22.4M+14.0% | $19.6M-47.2% | $37.2M-20.4% | $46.8M |
| Accounts Receivable | N/A | $207.3M+12.7% | $184.0M-33.4% | $276.1M+7.4% | $257.2M+67.3% | $153.7M-5.7% | $163.1M-14.5% | $190.8M+44.1% | $132.4M+35.0% | $98.1M |
| Total Liabilities | N/A | $2.3B-5.4% | $2.4B-8.5% | $2.7B-11.7% | $3.0B+20.4% | $2.5B-5.2% | $2.6B+4.0% | $2.5B+30.3% | $1.9B+4.0% | $1.9B |
| Current Liabilities | N/A | $424.0M-19.6% | $527.2M-20.0% | $659.2M+12.8% | $584.5M+72.1% | $339.6M+5.8% | $321.1M-22.2% | $412.8M+42.2% | $290.3M+34.0% | $216.6M |
| Non-Current Liabilities | N/A | $1.9B-1.5% | $1.9B-4.7% | $2.0B-17.6% | $2.4B+12.2% | $2.2B-6.7% | $2.3B+9.1% | $2.1B+28.2% | $1.7B+0.1% | $1.7B |
| Long-Term Debt | $906.8M+35.5% | $669.1M-3.4% | $692.3M-13.4% | $799.1M-38.2% | $1.3B-14.8% | $1.5B+2.1% | $1.5B+12.8% | $1.3B+29.7% | $1.0B0.0% | $1.0B |
| Total Equity | $1.6B-17.0% | $2.0B-15.0% | $2.3B-8.6% | $2.5B+55.4% | $1.6B+122.9% | $725.6M-61.7% | $1.9B-8.3% | $2.1B+67.5% | $1.2B+4.8% | $1.2B |
| Retained Earnings | -$1.4Bn/m | -$895.1Mn/m | -$957.1Mn/m | -$740.2Mn/m | -$1.8Bn/m | -$2.7Bn/m | -$1.4Bn/m | -$1.0Bn/m | -$1.0Bn/m | -$941.5M |
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments, Goodwill.
VET Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2540-F | FY2440-F | FY2340-F | FY2240-F | FY2140-F | FY2040-F | FY1940-F | FY1840-F | FY1740-F | FY1640-F |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | $672.0M-13.4% | $776.0M-42.1% | $1.3B+105.3% | $653.1M+66.5% | $392.2M-38.3% | $635.3M+6.2% | $598.1M+26.1% | $474.5M+25.0% | $379.5M |
| Investing Cash Flow | N/A | -$440.9Mn/m | -$436.6Mn/m | -$782.8Mn/m | -$367.6Mn/m | -$314.8Mn/m | -$477.3Mn/m | -$541.7Mn/m | -$277.8Mn/m | -$263.1M |
| Financing Cash Flow | N/A | -$238.9Mn/m | -$242.6Mn/m | -$553.0Mn/m | -$284.5Mn/m | -$94.6Mn/m | -$156.6Mn/m | -$71.8Mn/m | -$210.7Mn/m | -$97.9M |
| Dividends Paid | N/A | $50.7M+7.9% | $47.0M+94.5% | $24.2Mn/m | $0-100.0% | $92.3M-69.4% | $302.1M+24.8% | $242.0M+51.4% | $159.8M+104.9% | $78.0M |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Share Buybacks.
VET Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2540-F | FY2440-F | FY2340-F | FY2240-F | FY2140-F | FY2040-F | FY1940-F | FY1840-F | FY1740-F | FY1640-F |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | -37.0%-34.0pp | -3.0%+8.8pp | -11.8%-50.3pp | 38.5%-17.8pp | 56.3% | -133.0% | 1.9%-15.9pp | 17.8%+11.7pp | 6.1%+25.4pp | -19.3% |
| Return on Equity | -29.4%-27.8pp | -1.7%+6.2pp | -7.8%-46.5pp | 38.6%-17.0pp | 55.6%+219.6pp | -164.0%-165.3pp | 1.3%-8.3pp | 9.6%+5.6pp | 4.0%+14.2pp | -10.1% |
| Return on Assets | N/A | -0.8%+3.1pp | -3.8%-22.6pp | 18.8%-0.7pp | 19.4%+56.4pp | -36.9%-37.5pp | 0.6%-3.8pp | 4.3%+2.8pp | 1.6%+5.5pp | -3.9% |
| Current Ratio | N/A | 0.95-0.2x | 1.18+0.4x | 0.80+0.2x | 0.630.0x | 0.60-0.2x | 0.84+0.1x | 0.760.0x | 0.72-0.1x | 0.78 |
| Debt-to-Equity | 0.56+0.2x | 0.340.0x | 0.300.0x | 0.32-0.5x | 0.80-1.3x | 2.09+1.3x | 0.78+0.1x | 0.64-0.2x | 0.820.0x | 0.86 |
| Liabilities-to-Equity | N/A | 1.18+0.1x | 1.060.0x | 1.06-0.8x | 1.86-1.6x | 3.44+2.0x | 1.39+0.2x | 1.23-0.4x | 1.580.0x | 1.59 |
| Asset Turnover | N/A | 0.25-0.1x | 0.32-0.2x | 0.49+0.1x | 0.35+0.1x | 0.280.0x | 0.30+0.1x | 0.240.0x | 0.26+0.1x | 0.20 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| VERMILION ENERGY INC. VET | FY2025 | $1.3B | -$476.7M | -37.0% | $2.2B | 28/100 |
| Dorchester Minerals LP DMLP | FY2025 | $152.8M | $57.4M | 37.5% | $1.5B | 74/100 |
| Vitesse Energy, Inc.. VTS | FY2025 | $274.0M | $25.3M | 9.2% | $768.4M | 49/100 |
| Mach Natural Resources LP Common Units MNR | FY2025 | $1.2B | $143.0M | 12.2% | $1.8B | 58/100 |
| Kimbell Royalty Partners, LP Common Units KRP | FY2025 | $333.8M | $90.9M | 27.2% | $1.7B | 71/100 |
| HighPeak Energy, Inc. HPK | FY2025 | $863.4M | $19.0M | 2.2% | $1.5B | 44/100 |
Where VERMILION ENERGY INC. Ranks
Frequently Asked Questions
What is VERMILION ENERGY INC.'s annual revenue?
VERMILION ENERGY INC. (VET) reported $1.3B in total revenue for fiscal year 2025. This represents a 19.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is VERMILION ENERGY INC.'s revenue growing?
VERMILION ENERGY INC. (VET) revenue grew by 19.9% year-over-year, from $1.1B to $1.3B in fiscal year 2025.
Is VERMILION ENERGY INC. profitable?
No, VERMILION ENERGY INC. (VET) reported a net loss of $476.7M in fiscal year 2025, with a net profit margin of -37.0%.
How much debt does VERMILION ENERGY INC. have?
As of fiscal year 2025, VERMILION ENERGY INC. (VET) had $13.9M in cash and equivalents against $906.8M in long-term debt.
What is VERMILION ENERGY INC.'s net profit margin?
VERMILION ENERGY INC. (VET) had a net profit margin of -37.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is VERMILION ENERGY INC.'s return on equity (ROE)?
VERMILION ENERGY INC. (VET) has a return on equity of -29.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is VERMILION ENERGY INC.'s debt-to-equity ratio?
VERMILION ENERGY INC. (VET) had a debt-to-equity ratio of 0.56 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is VERMILION ENERGY INC.'s P/E ratio?
VERMILION ENERGY INC. (VET) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $2.2B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is VERMILION ENERGY INC.'s price-to-sales ratio?
VERMILION ENERGY INC. (VET) trades at 1.7x sales, its market capitalization divided by $1.3B revenue, FY2025. The market capitalization is $2.2B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How financially healthy is VERMILION ENERGY INC.?
VERMILION ENERGY INC. (VET) scores 28 out of 100 on our Financial Health Score, indicating weak standing within its energy companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For VERMILION ENERGY INC. it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.